Over the years, scientific research has led to the development of several pharmacological therapies for this disease. Now, a study coordinated by the University of Trento (Italy) marks a turning point, as it identified a gene therapy for individuals with cystic fibrosis caused by a specific mutation and for whom there was no treatment available until now. They are about 10% of all those with the disease. The results open up further prospects because they could lead to a definitive cure for patients with cystic fibrosis who are currently dependent on drugs.

A new ultra-efficient microchip developed at MIT enables resource-constrained wireless biomedical devices to implement post-quantum encryption protocols that can defend against cyberattacks from powerful quantum computers.

New research using data from the Canadian Longitudinal Study on Aging (CLSA) reveals that employment stability and in-person work buffered older adults against depression during the first year of COVID-19.